AutoGenomics Invited to Present at the 2009 JPMorgan Healthcare Conference
About JPMorgan 27th Annual Healthcare Conference: JPMorgan's premier annual conference on the healthcare industry will feature more than 300 public and private companies over four days of simultaneous sessions.
AutoGenomics Inc., a privately held company based in Carlsbad, CA, has developed an automated, microarray based multiplexing diagnostic platform that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious disease, cancer and pharmacogenetics. With the discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed leading to the era of personalized medicine. www.autogenomics.com
SOURCE AutoGenomics Inc.
You May Also Like